Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma. [electronic resource]
Producer: 19960604Description: 794-7 p. digitalISSN:- 0007-0920
- Adult
- Aged
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cyclophosphamide -- administration & dosage
- Drug Administration Schedule
- Epirubicin -- administration & dosage
- Female
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Multiple Myeloma -- drug therapy
- Myeloproliferative Disorders -- chemically induced
- Peptichemio -- administration & dosage
- Prednisone -- administration & dosage
- Recombinant Proteins
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.